Bad for Short-termers.Good for Long-termers (because of this coy's track record and potential). I and a shareholder and HOLD. Will top up if SP hits .75 tomorrow.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution